Interventional Study Collecting Quantitative and Qualitative Data About Patient With Non Treated Cancer
NCT ID: NCT01647477
Last Updated: 2016-07-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
90 participants
INTERVENTIONAL
2012-12-31
2016-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Factors Influencing Inclusion in Digestive Cancer Clinical Trials
NCT02894775
Does the Invitation by the General Practitioner Improve Patients' Participation in Colorectal Cancer Screening?
NCT01279278
Impact of the Distribution to Attending Physicians of a Nominative List of Their Patients Not Participating in the Organised Screening of Colorectal Cancer
NCT02515344
Early Detection of Treatment Failure in Metastatic Colorectal Cancer Patients
NCT05068531
Circulating Tumor Cells and Neutrophils Count for Colorectal Metastatic Cancer
NCT05793775
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
questionnaires
4 questionnaires to answer at baseline 45 minutes approx.
questionnaires
questionnaires to answer at baseline 45 minutes
interview
semi directive interview 105 patients
interview
25 minutes of semi directive interview
questionnaires
questionnaires to answer at baseline 45 minutes
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
interview
25 minutes of semi directive interview
questionnaires
questionnaires to answer at baseline 45 minutes
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* oral cavity cancer, oropharynx cancer, hypopharynx cancer, larynx cancer
* non treated cancer
* patient informed of his diagnosis
* speak fluent french
* patient covered by health insurance
* signed informed consent
* no speech troubles
* patient consents being recorded
Exclusion Criteria
* psychological history
* patient under guardianship
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Oscar Lambret
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Veronique CHRISTOPHE, MDPhD
Role: STUDY_DIRECTOR
Lille 3 University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier
Boulogne-sur-Mer, , France
CH
Lens, , France
Oscar Lambret Center
Lille, , France
Centre Hospitalier Régional et Universitaire - Hopital HURIEZ
Lille, , France
La Louviere Hospital
Lille, , France
Gray Center
Maubeuge, , France
Centre Médical Spécialisé du Littoral
Saint Martin Les Boulogne, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DEREDIA - 1110
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.